![Are There Benefits in Adding Catechol-O Methyltransferase Inhibitors in the Pharmacotherapy of Parkinson's Disease Patients? A Systematic Review - IOS Press Are There Benefits in Adding Catechol-O Methyltransferase Inhibitors in the Pharmacotherapy of Parkinson's Disease Patients? A Systematic Review - IOS Press](https://content.iospress.com/media/jpd/2018/8-2/jpd-8-2-jpd171225/jpd-8-jpd171225-g001.jpg?width=755)
Are There Benefits in Adding Catechol-O Methyltransferase Inhibitors in the Pharmacotherapy of Parkinson's Disease Patients? A Systematic Review - IOS Press
![Pharmaceutics | Free Full-Text | Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs | HTML Pharmaceutics | Free Full-Text | Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-13-00508/article_deploy/html/images/pharmaceutics-13-00508-g003.png)
Pharmaceutics | Free Full-Text | Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs | HTML
![Advances and Challenges in the Dosage Form Design for the Treatment of Parkinson's Disease - Ming Ming Wen - Discovery Medicine Advances and Challenges in the Dosage Form Design for the Treatment of Parkinson's Disease - Ming Ming Wen - Discovery Medicine](https://www.discoverymedicine.com/Ming-ming-Wen/files/2013/02/discovery_medicine_no_79_ming_ming_wen_figure_1.png)
Advances and Challenges in the Dosage Form Design for the Treatment of Parkinson's Disease - Ming Ming Wen - Discovery Medicine
![Hypothetical mechanism of COMT inhibition of the methabolic pathway of... | Download Scientific Diagram Hypothetical mechanism of COMT inhibition of the methabolic pathway of... | Download Scientific Diagram](https://www.researchgate.net/profile/Peter-Valkovic/publication/7861578/figure/fig1/AS:277771591929862@1443237316452/Hypothetical-mechanism-of-COMT-inhibition-of-the-methabolic-pathway-of-homocysteine-A.png)
Hypothetical mechanism of COMT inhibition of the methabolic pathway of... | Download Scientific Diagram
![Entacapone and Tolcapone, Two Catechol O-Methyltransferase Inhibitors, Block Fibril Formation of α-Synuclein and β-Amyloid and Protect against Amyloid-induced Toxicity* - Journal of Biological Chemistry Entacapone and Tolcapone, Two Catechol O-Methyltransferase Inhibitors, Block Fibril Formation of α-Synuclein and β-Amyloid and Protect against Amyloid-induced Toxicity* - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/bca4b00f-60cf-4910-99a9-c81dd7bd7256/gr10.jpg)